Skip Navigation

European Heart Journal 2001 22(2):103-104; doi:10.1053/euhj.2000.2459
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yusuf, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yusuf, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Hotline Editorial

Clinical, public health, and research implications of the Heart Outcomes Prevention Evaluation (HOPE) Study

S. Yusuf

Division of Cardiology and Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada

References

  1. N Engl J Med. 2000;342:145–153[Abstract/Free Full Text]
  2. N Engl J Med. 2000;342:154–160[Abstract/Free Full Text]
  3. Flather MD, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:1575–1581[CrossRef][ISI][Medline]
  4. Lonn E, Yusuf S, Jha P. Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection. Circulation. 1994;4:2056–2069
  5. Lonn EM, Dzavik V, Yusuf S. Results of the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 1999;100:I–185
  6. Sleight P, Yusuf S, Pogue J. Reduction of events by ramipril in high-risk subjects is largely unrelated to blood pressure decrease. Presented at the 49th Annual Scientific Session of the American Congress of Cardiology, March 12–15, 2000. Anaheim (CA). J Am Coll Cardiol. 2000;35:284A
  7. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ. 1989;299:1187–1192[ISI][Medline]
  8. N Engl J Med. 1994;330:1029–1035[Abstract/Free Full Text]
  9. Lancet. 1999;354:447–455[CrossRef][ISI][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
M. W Clarke, N. C Ward, J. H. Wu, J. M Hodgson, I. B Puddey, and K. D Croft
Supplementation with mixed tocopherols increases serum and blood cell {gamma}-tocopherol but does not alter biomarkers of platelet activation in subjects with type 2 diabetes
Am. J. Clinical Nutrition, January 1, 2006; 83(1): 95 - 102.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yusuf, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yusuf, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?